基因测序设备制造商 Illumina 公司今日盘前股价大跌5.68%,引发市场广泛关注。
消息面上,Illumina 公司周四晚间预测2025年营收将大幅低于华尔街分析师的平均预期,为42.8亿至44亿美元,低于分析师平均预期的43.9亿美元中点。这令投资者担忧该公司的增长前景,纷纷抛售股票,推动股价在盘前大幅下挫。
分析人士指出,此前华尔街多家机构已先期下调对 Illumina 公司目标股价的评级,反映出市场对该公司前景的担忧。目前,Illumina 未能解释此次收入预期下调的原因,也未说明是否与最近被中国列入不可靠实体清单有关。市场预计,该公司未来或将面临更大不确定性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.